Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Clinical trial NCT00471471 · COMPLETED

Trial details

NCT number: NCT00471471
Sponsor: Ahmad Tarhini
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intraocular Melanoma Malignant Conjunctival Neoplasm Melanoma (Skin)

Start date: 2008-10-01
Primary completion: 2011-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.